{
    "SPADE_N_01426": {
        "Clinical Information": [],
        "Patent Information": [
            {
                "Patent No": "US 7078380 B2",
                "Patent Link": "http://www.lens.org/lens/patent/US_7078380_B2",
                "Patent Type": "Granted Patent",
                "Publication Date": "2006-7-18",
                "Family Info": "CA2426012A1,EP1334117A1,EP1334117B1,US20040106544,WO2002036612A1",
                "Patent Title": "Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane associating elements.",
                "Abstract": "The invention concerns agents with anti-bacterial activity and methods and intermediates for their production. The present invention further concerns the use of such agents for the treatment of bacterial infections in animals, including man. The agents are derivatives of vancomycin-type antibiotics, of structure: V-L-W-X; wherein V is a glycopeptide moiety which inhibits peptidoglycan biosynthesis in bacteria; L is a linking group; W is a peptidic membrane-associating element such as an element based on naturally-occurring animal or bacterial peptide antibiotics; and X is hydrogen or a membrane-insertive element."
            }
        ],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_01426",
            "Peptide Name": "Caerin-1.1 (Frogs, amphibians, animals)",
            "Source": "Litoria splendida (Magnificent tree frog) (Litoria gilleni) (Litoria caerulea)",
            "Family": "Belongs to the frog skin active peptide family (Caerin subfamily)",
            "Gene": "Not found",
            "Sequence": "GLLSVLGSVAKHVLPHVVPVIAEHL",
            "Sequence Length": 25,
            "UniProt Entry": [
                "http://www.uniprot.org/uniprot/P62568",
                "http://www.uniprot.org/uniprot/P62569",
                "http://www.uniprot.org/uniprot/Q800R2",
                "http://www.uniprot.org/uniprot/P56226"
            ],
            "Protein Existence": "Protein level",
            "Biological Activity": [
                "Antimicrobial",
                "Antibacterial",
                "Anti-Gram+",
                "Anti-Gram-",
                "Antiviral"
            ],
            "Target Organism": "[Ref.15203252]Gram-positive bacteria:Bacillus cereus (MIC=50 µg/ml), Leuconostoc lactis (MIC=1.5 µg/ml), Listeria innocua (MIC=25 µg/ml), Micrococcus luteus (MIC=12.5 µg/ml), Staphylococcus aureus (MIC=3-12 µg/ml), Staphylococcus epidermis (MIC=12.5 µg/ml), Streptococcus uberis (MIC=12.5 µg/ml);Gram-negative bacterium:Pasteurella multocida (MIC=25 µg/ml).[Ref.16140737]Virus:HIV:inhibit 50% of PBS-treated HIV infection of T cells(IC50=7.8 μM);inhibition of HIV transfer by dendritic cells to T cells(IC50=12.6 μM)",
            "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry",
            "Cytotoxicity": "No cytotoxicity information found in the reference(s) presented",
            "Binding Target": "Cell membrane",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Amidation",
            "Stereochemistry": "L",
            "Structure Description": "The peptide adopts two well-defined helices from Leu2 to Lys11 and from Val17 to His24 separated by a region of less-defined helicity and greater flexibility.",
            "Formula": "C121H202N32O30",
            "Mass": 2585.09,
            "PI": 7.02,
            "Net Charge": 3,
            "Hydrophobicity": 1.19,
            "Half Life": "Mammalian:30 hourYeast:>20 hourE.coli:>10 hour",
            "Function": "Antibacterial and antiviral peptides that adopt an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.",
            "Tissue specificity": "Secreted by the skin parotoid and/or rostral glands.",
            "Domain": "Contains two amphipathic alpha helix regions separated by a region of less-defined helicity and greater flexibility.",
            "Miscellaneous": "Caerin 1.1 completely inhibits HIV infection of T cells within minutes of exposure to virus at concentrations that were not toxic to target cells (J Virol. 2005 Sep;79(18)",
            "PTM": "C-terminal amidation.",
            "Literature": [
                {
                    "Title": "Antimicrobial peptides from amphibian skin potently inhibit human immunodeficiency virus infection and transfer of virus from dendritic cells to T cells.",
                    "Pubmed ID": "16140737",
                    "Reference": "J Virol. 2005 Sep;79(18)11598-606.",
                    "Author": "VanCompernolle SE, Taylor RJ, Oswald-Richter K, Jiang J, Youree BE, Bowie JH, Tyler MJ, Conlon JM, Wade D, Aiken C, Dermody TS, KewalRamani VN, Rollins-Smith LA, Unutmaz D.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=16140737"
                },
                {
                    "Title": "The solution structure and activity of caerin 1.1, an antimicrobial peptide from the Australian green tree frog, Litoria splendida.",
                    "Pubmed ID": "9266696",
                    "Reference": "Eur J Biochem. 1997 Jul 15;247(2)545-557.",
                    "Author": "Wong H, Bowie JH, Carver JA.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=9266696"
                },
                {
                    "Title": "Antimicrobial peptides from hylid and ranin frogs originated from a 150-million-year-old ancestral precursor with a conserved signal peptide but a hypermutable antimicrobial domain.",
                    "Pubmed ID": "12709067",
                    "Reference": "Eur J Biochem. 2003 May;270(9)2068-2081.",
                    "Author": "Vanhoye D, Bruston F, Nicolas P, Amiche M.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=12709067"
                },
                {
                    "Title": "Host-defence peptides of Australian anurans structure, mechanism of action and evolutionary significance.",
                    "Pubmed ID": "15203252",
                    "Reference": "Peptides. 2004 Jun;25(6)1035-1054.",
                    "Author": "Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=15203252"
                },
                {
                    "Title": "Peptides from Australian frogs. Structures of the caerins and caeridin 1 from Litoria splendida.",
                    "Pubmed ID": "",
                    "Author": "Tyler M.J.,Wallace J.C.,Bowie J.H.,Waugh R.J.,Stone D.J.M."
                }
            ],
            "Frequent Amino Acids": "VLH",
            "Absent Amino Acids": "CDFMNOQRTUWY",
            "Basic Residues": 4,
            "Acidic Residues": 1,
            "Hydrophobic Residues": 16,
            "Polar Residues": 14,
            "Positive Residues": 4,
            "Negative Residues": 1,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_19812",
                    "Similarity": 1.0,
                    "Sequence": "GLLSVLGSVAKHVLPHVVPVIAEHL"
                },
                {
                    "SPADE_ID": "SPADE_N_01428",
                    "Similarity": 0.96,
                    "Sequence": "GLLGVLGSVAKHVLPHVVPVIAEHL"
                },
                {
                    "SPADE_ID": "SPADE_N_01429",
                    "Similarity": 0.96,
                    "Sequence": "GLLSVLGSVAQHVLPHVVPVIAEHL"
                }
            ]
        }
    }
}